Obesity

New global syndicated survey highlights a striking contradiction at the heart of how obesity is understood, especially by those living with it.

New 14-country study from Ipsos reveals self-blame, outdated narratives and a hidden daily toll.

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.

Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.

Security, Inflation, Perils of Perception … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.

Ipsos has launched three new syndicated studies to monitor and anticipate changes in the rapidly evolving landscape of obesity treatment.